| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 24,772 | 25,179 | 25,399 | 37,608 |
| Marketable securities | 233,613 | 267,168 | 176,773 | 171,911 |
| Restricted cash | NaN | NaN | NaN | 114 |
| Accounts receivable, net | 343 | 329 | NaN | NaN |
| Restricted cash | NaN | 0 | 0 | 100 |
| Inventory | 3,498 | 2,936 | 949 | NaN |
| Prepaid expenses and other current assets | 6,141 | 5,800 | 3,876 | 3,969 |
| Total current assets | 268,367 | 301,412 | 206,997 | 213,602 |
| Property and equipment, net | 1,096 | 1,189 | 1,258 | 1,169 |
| Operating lease right-of-use asset | 619 | 734 | 847 | 959 |
| Other assets | 2,453 | 2,541 | 1,602 | 1,602 |
| Total assets | 272,535 | 305,876 | 210,704 | 217,332 |
| Accounts payable | 10,929 | 4,167 | 4,323 | 2,854 |
| Accrued liabilities | 14,877 | 17,020 | 11,993 | 7,544 |
| Total current liabilities | 25,806 | 21,187 | 16,316 | 10,398 |
| Operating lease liability, net | 237 | 350 | 461 | 569 |
| Total liabilities | 26,043 | 21,537 | 16,777 | 10,967 |
| Common stock, par value of 0.00001 per share 300,000,000 shares authorized 31,354,394 and 31,344,782 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 515,570 | 511,237 | 384,944 | 380,871 |
| Accumulated deficit | -268,629 | -227,141 | -191,245 | -174,545 |
| Accumulated other comprehensive (loss) income | -450 | 242 | 227 | 38 |
| Total stockholders equity | 246,492 | 284,339 | 193,927 | 206,365 |
| Total liabilities and stockholders equity | 272,535 | 305,876 | 210,704 | 217,332 |
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)